Back
March 18, 2022

VSS Science Updates During Pandemic Times #10

Goal: Our newsletter aims at providing regular updates on the science and the truth behind the current pandemic. We are dedicated to bringing the real science to the table and sharing how the truth invalidates the current narrative, for which scientific evidence is now increasingly lacking. We’ll provide an update on a (semi-)weekly basis, on Mondays and/or Fridays. We sincerely hope this newsletter will contribute to raising awareness about the consequences of human intervention in this pandemic, particularly of mass vaccination, from both an individual and public health perspective.

1. Children In China Diagnosed with Leukemia After Taking Chinese Vaccines

“My baby was perfectly healthy before the vaccine dose,” Li (an alias), from China’s north-central Gansu Province, told The Epoch Times. “I took her for a health check. Everything was normal.”

https://www.zerohedge.com/geopolitical/children-china-diagnosed-leukemia-after-taking-chinese-vaccines

2. Thailand Pays Out $45 Million as Compensation Following Covid-19 Vaccine Adverse Reactions

“Thailand's National Health Security Office (NHSO) has so far paid 1.509 billion baht ($45.65 million) as compensation to 12,714 people who developed side-effects after they received Covid-19 vaccines.”

https://www.phnompenhpost.com/international/thailand-pay-45m-over-vaccine-side-effects

3. Merck’s Covid-19 Pill Heavily Used So Far Despite Concerns

“Among the concerns: Lab testing, though not the clinical trials, suggested molnupiravir could cause birth defects. Also, there are some signs the drug’s use in study subjects led to a higher frequency of mutations in the virus, which could result in variants.”

https://www.wsj.com/articles/mercks-covid-19-pill-heavily-used-so-far-despite-concerns-11647250200

4. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

“Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of COVID-19 vaccination.”

https://jamanetwork.com/journals/jama/fullarticle/2788346

5. Biden Administration Targeting Parents in New Ad Campaign Effort to Increase Adolescent Covid Vaccinations

"We took an oath to do what's best for our patients. So we want you to know we trust the COVID vaccine. For ourselves, for our patients, for our kids. So should you," the group says in the ad. 

https://www.cbsnews.com/news/we-trust-the-covid-vaccine-say-heads-of-top-medical-groups-in-plea-to-parents/

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
December 19, 2024

Dynamics of SARS-CoV-2 in highly C-19 vaccinated populations in a nutshell

Read
December 2, 2024

Are Newly Emerging Saltation Variants the Desperate Harbingers of an Imminent Surge in COVID-19 Case Fatalities in Highly C-19 Vaccinated Populations?

Read
November 23, 2024

Bird Flu Gain-of-Function Study Fueling Vaccine Development, Fears of Human Transmission

Read
Voices for Science and solidarity, © 2023